ATPs: does Commission's proposal take sufficient account of hTEPs needs?
This article was originally published in Clinica
Executive Summary
With the publication of the European Commission's proposal for an advanced therapy products (ATPs) Regulation making human tissue engineered products a subset of pharmaceuticals, the medical technology industry is scrutinising the text to find measures that are specific to hTEPs and supportive of the hTEPs industry.